论文部分内容阅读
基因,具有遗传效应的DNA片段,会成为中国创投界的新尤物吗?只需要一滴血或一点唾液,就能查找病源或者预测患上疾病的几率。基因检测是从人体血液、体液或细胞中提取基因序列并进行测定,通常癌症相关基因的检出可提示患病的潜在可能。基因检测技术包含FISH、PCR、基因芯片及测序技术,其中,测序技术最受瞩目,历经了四代的创新发展,在成本、通量水平和精确性上已经达到了临床普及应用的水平。据美国知名调查机构Grand View Research(GVR)最新的研报预测,2022年全球基因检测市场规模可达100.4亿美元。在美国现有1000多家医疗机构开展基因测序,每年服务人群接
Genes, DNA fragments with genetic effects, will become the new creature in China’s venture capital community? Only need a drop of blood or a little saliva, you can find the source or predict the risk of suffering from the disease. Genetic testing is the extraction of gene sequences from human blood, body fluids or cells and determination of the gene. Detection of cancer-related genes can often indicate the potential for illness. Gene detection technology includes FISH, PCR, microarray and sequencing technology. Among them, sequencing technology has attracted the most attention. After four generations of innovation and development, it has reached the level of clinical popularization and application in terms of cost, flux level and accuracy. According to the latest research report of Grand View Research (GVR), a well-known investigation agency in the United States, the global genetic testing market can reach 10.04 billion U.S. dollars by 2022. In the United States more than 1,000 medical institutions to carry out gene sequencing, serving the crowd each year